- Home
- FOXO vs DOMH Comparison
FOXO vs DOMH Comparison
Compare FOXO & DOMH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- FOXO
- DOMH
- Stock Information
- Founded
- FOXO 2019
- DOMH 1967
- Country
- FOXO United States
- DOMH United States
- Employees
- FOXO N/A
- DOMH N/A
- Industry
- FOXO Retail: Computer Software & Peripheral Equipment
- DOMH Biotechnology: Pharmaceutical Preparations
- Sector
- FOXO Technology
- DOMH Health Care
- Exchange
- FOXO Nasdaq
- DOMH Nasdaq
- Market Cap
- FOXO 4.9M
- DOMH 74.9M
- IPO Year
- FOXO N/A
- DOMH N/A
- Fundamental
- Price
- FOXO $0.15
- DOMH $5.25
- Analyst Decision
- FOXO
- DOMH
- Analyst Count
- FOXO 0
- DOMH 0
- Target Price
- FOXO N/A
- DOMH N/A
- AVG Volume (30 Days)
- FOXO 5.9M
- DOMH 1.5M
- Earning Date
- FOXO 11-19-2024
- DOMH 05-08-2025
- Dividend Yield
- FOXO N/A
- DOMH 5.93%
- EPS Growth
- FOXO N/A
- DOMH N/A
- EPS
- FOXO N/A
- DOMH N/A
- Revenue
- FOXO $1,341,000.00
- DOMH $12,589,000.00
- Revenue This Year
- FOXO N/A
- DOMH N/A
- Revenue Next Year
- FOXO N/A
- DOMH N/A
- P/E Ratio
- FOXO N/A
- DOMH N/A
- Revenue Growth
- FOXO 196.03
- DOMH 1117.50
- 52 Week Low
- FOXO $0.13
- DOMH $0.83
- 52 Week High
- FOXO $1.30
- DOMH $13.58
- Technical
- Relative Strength Index (RSI)
- FOXO 36.77
- DOMH 44.59
- Support Level
- FOXO $0.14
- DOMH $5.18
- Resistance Level
- FOXO $0.17
- DOMH $8.55
- Average True Range (ATR)
- FOXO 0.02
- DOMH 1.30
- MACD
- FOXO 0.00
- DOMH -0.56
- Stochastic Oscillator
- FOXO 8.00
- DOMH 1.45
About FOXO FOXO Technologies Inc.
FOXO Technologies Inc is a technology platform company focused on commercializing longevity science through products and services that serve the life insurance industry. FOXO's epigenetic technology applies AI to DNA methylation to identify molecular biomarkers of human health and aging. The company has two reportable business segments, FOXO Labs and FOXO Life.
About DOMH Dominari Holdings Inc.
Dominari Holdings Inc is a biotechnology company with a diverse portfolio of small-molecule anticancer and antiviral therapeutics in development. The company's oncology therapeutics include treatments for pancreatic cancer, acute myeloid leukemia, and acute lymphoblastic leukemia.